Obalon Therapeutics, Inc. (OBLN) |
3.05 -0.19 (-5.86%) 06-16 00:00 |
Open: | 3.25 |
High: | 4.8 |
Low: | 2.948 |
Volume: | 26,469,075 |
Market Cap: | 5(M) |
PE Ratio: | -2.22 |
Exchange: | NASDAQ Global Market |
Industry: | Medical - Devices |
Sector: | Healthcare |
Technical analysis | ||||
sell | buy |
Resistance 2: | 4.88 |
Resistance 1: | 3.88 |
Pivot price: | 3.26 |
Support 1: | 2.26 |
Support 2: | 1.88 |
52w High: | 32.31003 |
52w Low: | 1.980001 |
Obalon Therapeutics, Inc., a vertically integrated medical device company, focuses on developing and commercializing medical devices to treat people with obesity. The company offers the Obalon Balloon System designed to provide weight loss in patients with obesity. Its Obalon Balloon System comprises of a swallow able capsule that contains an inflatable balloon attached to a microcatheter; the Obalon Navigation System console, which is a combination of hardware and software used to track and display the location of the balloon during placement; the Obalon Touch Inflation Dispenser, which is a semi-automated, hand-held inflation device used to inflate the balloon once it is placed; and a disposable canister filled with mixture of gas. As of February 27, 2020, it had three company-managed retail treatment centers in California. Obalon Therapeutics, Inc. was founded in 2008 and is headquartered in Carlsbad, California.
EPS | -1.594 |
Book Value | 0.600 |
PEG Ratio | 0.00 |
Gross Profit | 0.053 |
Profit Margin (%) | 0.00 |
Operating Margin (%) | -711.27 |
Return on Assets (ttm) | -45.5 |
Return on Equity (ttm) | -120.3 |
Fri, 01 Dec 2023
ReShape and Obalon Merge in All-Stock Transaction - MD+DI
Fri, 22 Sep 2023
Gastric Balloon Market include Apollo Endosurgery, Inc., - openPR
Wed, 21 Apr 2021
Top Reddit Penny Stocks To Buy Today? 3 To Watch Right Now - Penny Stocks
Fri, 08 May 2020
William Plovanic Resigns as President and Chief Executive Officer and Will Continue to Serve Solely as Director - GlobeNewswire
Thu, 22 Aug 2019
The Daily Biotech Pulse: ViiV's Long-Acting HIV Drug Meets Study Goal, Chinese Cheer For FibroGen, Retrop - Benzinga
Fri, 19 Jan 2018
San Diego's Obalon Preps $35M Offering - BioSpace
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |